The MPN Research Foundation Announces New Executive Director
The MPN Research Foundation is proud to announce the appointment of Kapila Viges as the Chicago, IL-based nonprofit’s new Executive Director. Through MPN research, advocacy, and education, the MPN Research Foundation brings together patients, researchers, and clinicians around the common goal of realizing new treatments and, ultimately, a cure for polycythemia vera, essential thrombocythemia, and myelofibrosis, known collectively as myeloproliferative neoplasms (MPN).
Kapila Viges comes to us with a long and strong background in supporting cancer research, biopharma interactions, and the development of creative partnerships to accelerate new therapy development. Kapila brings experience from public, academic, and industry sector leadership roles.
“The MPN Research Foundation has an impressive history in enabling disease knowledge and advancing new therapies for patients. It is a privilege to be part of the team and help navigate to the next chapter for the foundation.”
“Although we spoke to a number of very qualified candidates, our goal was to find someone with leadership skills and sense of strategy, but who would also be able to propel the Foundation to a new level of research funding and innovation. Kapila meets these criteria with flying colors,” said Barbara Van Husen, Chairman of the MPNRF Board. “Her experience includes management and strategy consulting in the biomedical industry, biomedical startup incubation and seed investing of translational research, and public-private-partnerships in economic development. Kapila joined us this fall.”